Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.955
-0.005 (-0.26%)
Nov 21, 2024, 11:29 AM EST - Market open

Caribou Biosciences Revenue

Caribou Biosciences had revenue of $2.02M in the quarter ending September 30, 2024, a decrease of -91.45%. This brings the company's revenue in the last twelve months to $11.48M, down -66.85% year-over-year. In the year 2023, Caribou Biosciences had annual revenue of $34.48M with 148.91% growth.

Revenue (ttm)
$11.48M
Revenue Growth
-66.85%
P/S Ratio
15.32
Revenue / Employee
$72,627
Employees
158
Market Cap
177.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 202012.36M6.57M113.56%
Dec 31, 20195.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 444.20M
Heron Therapeutics 137.74M
Biodesix 65.56M
Nanobiotix 45.22M
BrainsWay 38.63M
scPharmaceuticals 30.28M
Verastem 10.00M
Revenue Rankings